• EE705 Cost-Effectiveness Model of Lebrikizumab Compared to Dupilumab in the Treatment of Austrian Patients With Moderate to Severe Atopic Dermatitis

    Dec 1, 2024, 00:00

  • HPR91 Price Sensitivity and Uptake of Pharmaceuticals in Sweden and Finland: The Example of New Migraine Drugs

    Dec 1, 2024, 00:00

  • HTA49 Analysis of Funding Conditions for Orphan Medicines in Spain: Trends in Pricing Reimbursement

    Dec 1, 2024, 00:00

  • HTA70 Insights into NICE's Approach to Uncertainties in Health Technology Appraisals

    Dec 1, 2024, 00:00

  • CO128 The Association Between Intra- and Post-Operative Surgical Complications and Clinical and Economic Outcomes in Patients Undergoing Open Right Colectomy in the US

    Dec 1, 2024, 00:00

  • EE676 Economic Burden and Unmet Needs of Retinitis Pigmento Expert Perspective in Brazil and Mexico

    Dec 1, 2024, 00:00

  • HPR165 Pharmacoeconomic Evaluation Exemption and Deferral in Korea – Impact on Patient Access?

    Dec 1, 2024, 00:00

  • EE475 Cost-Benefit Analysis of Difficult Airway Management Techniques in Ukraine

    Dec 1, 2024, 00:00

  • EE690 The Impact of Caring for an Infant With Respiratory Syncytial Virus on Work-Related Outcomes: Insights From Caregivers Recruited From Canada, Germany, Italy, and Netherlands

    Dec 1, 2024, 00:00

  • EE665 Health Care Resource Use and Costs of Hemophilia A (HA) in French Adult Patients in 2022: A Nationwide Claims Database Analysis

    Dec 1, 2024, 00:00

  • HPR48 Relationship Between Genetic Heterogeneity and Acquired Resistance to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Targeted Literature Review

    Dec 1, 2024, 00:00

  • HPR173 Literature Analysis of Artificial Intelligence Applications in Clinical Trial Design for Enhanced Efficiency and Patient Outcomes

    Dec 1, 2024, 00:00

  • CO8 A Retrospective Analysis of the Impact of Approved Anti-Obesity Medications on Cardiovascular Disease Risk Among Patients With Obesity

    Dec 1, 2024, 00:00

  • HPR216 International Reference Pricing Analysis of Medicines in Türkiye by 2023

    Dec 1, 2024, 00:00

  • EE493 Cost-Utility Analysis of Trastuzumab Deruxtecan Versus Treatment of Physician’s Choice in HER2-Positive Metastatic Breast Cancer in Chinese Setting

    Dec 1, 2024, 00:00

  • HTA127 The Innovative Medicines Fund or the In Need of Medicines Fund: Analysis of NICE Technology Appraisals to Explore Barriers to Managed Access Agreements

    Dec 1, 2024, 00:00

  • EE670 Impact of Different Mapping Algorithms From Disease-Specific Measures to EQ-5D on Cost-Effectiveness Analysis in Atopic Dermatitis

    Dec 1, 2024, 00:00

  • EE268 Interim Burden of Disease Findings for Myasthenic Gravis-Resource Utilization Epidemiology, Survival, and Treatment Patterns (MG-REST) Study in Ontario, Canada

    Dec 1, 2024, 00:00

  • HSD43 Pain and Lesion Count in the Clinical Management of Actinic Keratosis in the Real-World Setting

    Dec 1, 2024, 00:00

  • EPH112 Prevalence and Costs of Potentially Inappropriate Medications for Elderly People Using Automated Multidose Dispensing Servi A Nationwide Register-Based Study

    Dec 1, 2024, 00:00

  • EE798 Evaluating the Potential Health and Economic Impact of V116, an Adult Specific 21-Valent Pneumococcal Conjugate Vaccine, on Invasive Pneumococcal Disease in Germany

    Dec 1, 2024, 00:00

  • HSD110 Statin Prescribing in Patients With Non-Alcoholic Steatohepatitis in the United States: An Analysis of 3 Real-World Data Sources

    Dec 1, 2024, 00:00

  • EE694 A Cost-Effectiveness Analysis of Radiofrequency Renal Denervation for Uncontrolled Hypertension Based on the SPYRAL HTN-ON Med Trial in the Netherlands

    Dec 1, 2024, 00:00

  • EE246 A Budget Impact Model Assessing Continuous Blood Glucose Monitoring Devices in Type 2 Diabetes Mellitus in Sweden

    Dec 1, 2024, 00:00

  • HPR210 Will We Have Access to Healthcare? Escalating Burden of Chronic Disease Hospitalizations: Evidence From Routine Hospital Data

    Dec 1, 2024, 00:00

  • EPH78 Prevalence of Depressive Symptoms Among College Students in Barranquilla, Colombia: A Cross-Sectional Study

    Dec 1, 2024, 00:00

  • EPH42 The Healthcare Resource Use Impact in Adults With Type 1 Diabetes Who Switched From a First to Another First or Next-Generation Basal Insulin Analogue: A Retrospective Linked Primary and Secondary Care Database Study in England

    Dec 1, 2024, 00:00

  • HSD113 Pilot Project for Implementing Value-Based Healthcare in Rheumatology for Inflammatory Arthritis Patients

    Dec 1, 2024, 00:00

  • EPH232 Unveiling the Hidden Burden: Respiratory Syncytial Virus in Dutch Older Adults and the Imperative Need for Vaccination

    Dec 1, 2024, 00:00

  • HTA113 Comparative Analysis of Traditional vs AI-Assisted Health Technology Assessment Dossier Writing

    Dec 1, 2024, 00:00

  • HPR39 Determinants of Prices of Oncological Drugs in France

    Dec 1, 2024, 00:00

  • HPR82 Feasibility Study on the Possibilities for Implementation of National Screen Program for Lung Cancer in CEE Countries With Focus on the Balkan Region

    Dec 1, 2024, 00:00

  • P12 How Does Unpaid Caregiving Affect EQ-5D? Does the Average Treatment Effect Differ for 3L and 5L?

    Dec 1, 2024, 00:00

  • EPH9 Influence of Front Nutritional Labeling on Consumer Choices Related to Ultra-Processed Foods: Scoping Review

    Dec 1, 2024, 00:00

  • HPR36 Balancing Trade-Offs With Simulation-Guided Negotiation: A Probabilistic Tipping Point Analysis for Comparison of Value-Based Contracts and Flat Discount Reimbursement Models for Cell and Gene Therapies

    Dec 1, 2024, 00:00

  • EE697 Cost-Effectiveness of Blood-Based Non-Invasive Testing Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population

    Dec 1, 2024, 00:00

  • HTA149 From Pilot to Practi Insights From the NICE Early Value Assessment for Digital Health Technologies

    Dec 1, 2024, 00:00

  • HTA145 Qualitative and Quantitative Evidence Synthesis Strategies to Support JCA and IRA Submissions

    Dec 1, 2024, 00:00

  • EE765 The Economic Burden of Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease in South Korea and Taiwan

    Dec 1, 2024, 00:00

  • HPR96 Price Monitoring of Anticancer Drugs Under Price Controlled Category in India

    Dec 1, 2024, 00:00

  • HTA25 Diverging Relative Clinical Benefit Assessment Across HAS and G-BA: A Forecast for EU HTA in Oncology Drugs

    Dec 1, 2024, 00:00

  • HTA20 National Perspectives on the European Joint Clinical Assessment: Insights From HTA Stakeholders in Four Countries

    Dec 1, 2024, 00:00

  • HSD108 Impact of Predictive Modelling and Application of Preventative Measures in Reducing Fall Rates in Domiciliary Care

    Dec 1, 2024, 00:00

  • HTA214 Trends Underlying Positive and Negative Decision-Making for New Treatments Targeting Rare Diseases (RD) Appraised by the National Institute for Health and Care Excellence (NICE) in 2023

    Dec 1, 2024, 00:00

  • EPH115 Estimating the Public Health Impact of Pediatric Vaccination Programs on Invasive Pneumococcal Disease in France

    Dec 1, 2024, 00:00

  • EE572 Pharmaco-Economic Evaluation of Therapeutic Drug Monitoring of 5-Fluorouracil in the Treatment of Colorectal Cancer

    Dec 1, 2024, 00:00

  • EPH264 Associations Between Antihypertensive Drugs and Risk of Sight-Threatening Diabetic Retinopathy in People With Type 2 Diabetes: A Population-Based Cohort Study

    Dec 1, 2024, 00:00

  • EE265 Cost-Effectiveness of Brexucabtagene Autoleucel for the Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 26 Years or Older in Greece

    Dec 1, 2024, 00:00

  • HSD25 Requirements to Ensure Patient Safety Through Paxlovid® Prescribing Supports in the Primary Care Setting in Ireland

    Dec 1, 2024, 00:00

  • HPR72 Coverage Evolution of Anti-Hemophilic Medicines Into the Public Health System of a Middle-Income Country

    Dec 1, 2024, 00:00

  • P44 Examining the Prediction Properties of a Visual Analogue Scale for Utility Measurement in End-Stage Liver Disease Pre and Post Transplantation

    Dec 1, 2024, 00:00

  • HTA17 NICE Early Value Assessment: A New Avenue for Evidence Generation and Early Market Access in the Digital Therapeutics Space in the United Kingdom

    Dec 1, 2024, 00:00

  • HPR244 Innovative Reimbursement Agreements Addressing the Challenges of Advanced Therapy Medicinal Products: Systematic Review for the Five Major European Healthcare Systems (EU5)

    Dec 1, 2024, 00:00

  • HPR178 Quantifying Health Inequity: An Umbrella Review of Systematic Literature Reviews on Sex-Based Differences in Health Outcomes

    Dec 1, 2024, 00:00

  • EE480 Healthcare Resource Utilization and Costs Related to Pertussis in Adults With and Without Underlying Conditions: A German Claims Data Analysis

    Dec 1, 2024, 00:00

  • Methods for Measuring and Valuing Informal Care: A Systematic Review and Meta-Analysis in Stroke [Editor's Choice]

    Dec 1, 2024, 00:00

  • HPR8 The Payment for Performance Environment for Drugs and Medical Devices in Romania

    Dec 1, 2024, 00:00

  • EE829 Quantifying Disease-Specific Indirect Economic Burden Using Survey Research Methods as a Component of Estimating the Total Economic Burden of a Disease

    Dec 1, 2024, 00:00

  • P49 Cost-Effectiveness (CE) of a Multi-Cancer Early Detection (MCED) Test Varies With Population Cancer Risk

    Dec 1, 2024, 00:00

  • HTA19 Predicting Acceptability of Quantitative Evidence Synthesis for Joint Clinical Assessment Submissions: A Rating Scale

    Dec 1, 2024, 00:00

  • HPR100 The Impact of Price Negotiation on the Pricing of Innovative Drugs in China

    Dec 1, 2024, 00:00

  • HSD111 Cost-Outcome Descriptive Analysis of an Internet Based Treatment for Depression, Social Anxiety, and Panic Disorder: A Post-Implementation Open Naturalistic Design Study

    Dec 1, 2024, 00:00

  • EPH82 Characterising Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis Patients in Secondary Care in England

    Dec 1, 2024, 00:00

  • EE814 Potential Return on Subscription to a Smartphone Based Biometric Health Risk Assessment Tool

    Dec 1, 2024, 00:00

  • EPH151 The Burden of Hospital-Acquired Venous Thromboembolism to Patients and Healthcare Systems in Ten Countries: A Health-Economic Analysis

    Dec 1, 2024, 00:00

  • HPR156 Understanding the Key Drivers, Barriers, and the Role of Different Socio-Economic Conditions When Vaccinating Against Invasive Meningococcal Serogroup B Disease in Europe: A Multi-Country Cross-Sectional Physician Survey

    Dec 1, 2024, 00:00

  • Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure

    Dec 1, 2024, 00:00

  • EE366 The Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection in France

    Dec 1, 2024, 00:00

  • HSD117 The Importance and Recognition of Hypo- and Hyperkalaemia in Prehospital Care

    Dec 1, 2024, 00:00

  • EPH223 Trends in Epidemiology and Mortality of Patients With Melanoma in Germany: A Retrospective Study Using German Claims Data

    Dec 1, 2024, 00:00

  • EPH86 Increased Healthcare Resources Utilization and Costs of Long COVID in Community-Managed Adult Patients in France

    Dec 1, 2024, 00:00

  • CO60 Superior Cardiovascular Benefits of SGLT2 Inhibitors Over DPP4 Inhibitors for Severe Diabetic Kidney Disease: A Population-Based Cohort Study

    Dec 1, 2024, 00:00

  • HTA88 The Value of Oncology-Related Endpoints Beyond Overall Survival in HTA Decision-Making

    Dec 1, 2024, 00:00

  • CO105 Impact of Glucagon-like Peptide 1 Receptor Agonist (GLP-1 RA) Non-Persistence on Body Mass Index, HBA1C, and Lipids: Analysis of Over 190,000 Adults Treated With Semaglutide, Liraglutide, and Tirzepatide in US Real-World Data

    Dec 1, 2024, 00:00

  • EPH93 Prevalence of Pulmonary Nodules (PNs) in 2020 During the Coronavirus Disease (COVID-19) Pandemic in the United States (US)

    Dec 1, 2024, 00:00

  • HTA198 Precedents for Reimbursed Highly Specialised Technologies Appraised By the National Institute for Health and Care Excellen Key Takeaways and Recommendations

    Dec 1, 2024, 00:00

  • EE286 Cost-Effectiveness of Nirmatrelvir/Ritonavir in Swedish Adults, Stratified by Age, Comorbidity and Vaccination Status, Compared to No Anti-Viral Treatment

    Dec 1, 2024, 00:00

  • EE553 Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada

    Dec 1, 2024, 00:00

  • Cover

    Dec 1, 2024, 00:00

  • EE624 Budget Impact of Intravenous Eptinezumab in the Prevention of Chronic Migraine Patients in United Arab Emirates

    Dec 1, 2024, 00:00

  • HTA223 How to Speed Up the Process of Introducing High-Value Innovative Technologies to the Health System: The Catalan Health System Innovation Access Program (PASS)

    Dec 1, 2024, 00:00

  • EE469 Cost-Utility Analysis of Nutrient-Dense Supplementation in Undernourished Children in Indonesia

    Dec 1, 2024, 00:00

  • EPH79 Impact of the COVID-19 Pandemic on Diabetes Mellitus Care in Portugal

    Dec 1, 2024, 00:00

  • HPR56 Exploring If a Price Premium Is Requested for Cancer Drugs That Seek Reimbursement on State-Subsidised Schemes in Ireland: An Analysis of Drugs That Have Undergone a Full HTA by the NCPE in Ireland Between 2019 and 2023

    Dec 1, 2024, 00:00

  • Enhancing Patient Response to Patient-Reported Outcome Measures: Insights From a Leading Dutch University Hospital

    Dec 1, 2024, 00:00

  • EPH224 Trends in Epidemiology and Mortality of Patients With Coronary Heart Disease in Germany: A Retrospective Study Using German Claims Data

    Dec 1, 2024, 00:00

  • EE659 Is Universal Genetic Testing Cost-Effective to Detect and Manage Lynch Syndrome in Singapore?

    Dec 1, 2024, 00:00

  • HPR35 Influence of Pharmaceutical Competition on Compensable Price Differential (EMI): A Dynamic in Favor of Freely Negotiated Hospital Price?

    Dec 1, 2024, 00:00

  • HTA11 Early Access Programs (EAPs) in Fran Reasons for Refusal

    Dec 1, 2024, 00:00

  • EE411 Budget Impact Analysis of Subcutaneous Infliximab (CT-P13 SC) for Treating Inflammatory Bowel Disease in Saudi Arabia: Analysis from Payer Perspective

    Dec 1, 2024, 00:00

  • EE294 Evaluating the Economic Burden of Therapeutic Inertia in People With Type 2 Diabetes in Saudi Arabia

    Dec 1, 2024, 00:00

  • EE547 Budget Impact Analysis of Epcoritamab for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy in Greece

    Dec 1, 2024, 00:00

  • EPH128 COVID-19 Is Here to Stay: Seasonal Endemic SARS-CoV-2 Infection Patterns Indicate Recurring Waves Adding to Respiratory and Cardiovascular Disease Burden in Germany

    Dec 1, 2024, 00:00

  • HTA104 Equity Is Not Equal: A Comparative Study of How Equity Is Considered by NICE, ICER, CDA-AMC, and PBAC

    Dec 1, 2024, 00:00

  • PT32 Economic Evaluation of Abdominal Aortic Aneurysm Screening in the Czech Republic

    Dec 1, 2024, 00:00

  • EPH156 Estimated Public Health Impact of Italian Smokers Switching to Smoke-Free Products: A Population Health Impact Modeling Study

    Dec 1, 2024, 00:00

  • HTA206 For Orphan Drugs Technology Assessments, One Size May Not Fit All: Will the Implementation of JCA Lead to Increased Access or Will It Just Lead to a Duplication of Work?

    Dec 1, 2024, 00:00

  • EE391 Psychometric Performance of EQ-5D-5L and VILL-UI, a New Condition-Specific Preference-Weighted Measure, in Patients With Age-Related Macular Degeneration: A Macustar Study Report

    Dec 1, 2024, 00:00

  • Editorial Board

    Nov 5, 2024, 08:49

  • Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe

    Nov 1, 2024, 00:00

  • Valuation of Multidimensional Health States With a Bolt-On: Is There a Shortcut? [Editor's Choice]

    Nov 1, 2024, 00:00

  • An Exploratory Study of Alternative Time Frames and Descriptors for EQ-5D-5L in Obstructive Airway Diseases Using Mixed Methods

    Nov 1, 2024, 00:00

  • Table of Contents

    Nov 1, 2024, 00:00

  • First-Line Treatment With Atezolizumab Plus Bevacizumab and Chemotherapy for US Patients With Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis

    Nov 1, 2024, 00:00

  • How Many Monte Carlo Samples Are Needed for Probabilistic Cost-Effectiveness Analyses?

    Nov 1, 2024, 00:00

  • Choice Consistency in Discrete Choice Experiments: Does Numeracy Skill Matter?

    Nov 1, 2024, 00:00

  • Development of a Prioritization Framework to Aid Healthcare Funding Decision Making in Health Technology Assessment in Australia: Application of Multicriteria Decision Analysis

    Nov 1, 2024, 00:00

  • When Are You Recovered? Defining Cutoff Points Using the Acute Respiratory Tract Infection Questionnaire

    Nov 1, 2024, 00:00

  • Attribute Development in Health-Related Discrete Choice Experiments: A Systematic Review of Qualitative Methods and Techniques to Inform Quantitative Instruments [Editor's Choice]

    Nov 1, 2024, 00:00

  • Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making: A Good Practices Report of an ISPOR Task Force [Editor's Choice]

    Nov 1, 2024, 00:00

  • Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch

    Nov 1, 2024, 00:00

  • EQ-5D-5L Population Scores in Mainland China: Results From a Nationally Representative Survey 2021

    Nov 1, 2024, 00:00

  • Measuring Healthcare Experiences Among People With Intellectual Disability: A Rapid Evidence Synthesis of Tools and Methods

    Nov 1, 2024, 00:00

  • Clinical Outcome Assessments Are Never “Validated” [Editor's Choice]

    Nov 1, 2024, 00:00

  • Assessing the Health and Welfare Benefits of Interventions Using the Wider Societal Impacts Framework [Editor's Choice]

    Nov 1, 2024, 00:00

  • Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey

    Nov 1, 2024, 00:00

  • The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers

    Nov 1, 2024, 00:00

  • Table of Contents

    Oct 1, 2024, 00:00

  • Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data

    Oct 1, 2024, 00:00

  • Uncertainty in Long-Term Relative Effectiveness of Medicines in Health Technology Assessment [Editor's Choice]

    Oct 1, 2024, 00:00

  • Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review

    Oct 1, 2024, 00:00

  • A New and Improved Experimental Design for the Discrete Choice Experiment Module of the EuroQol Valuation Technology Protocol

    Oct 1, 2024, 00:00

  • Patient-Reported Outcome Measures as an Intervention: A Comprehensive Overview of Systematic Reviews on the Effects of Feedback

    Oct 1, 2024, 00:00

  • Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands [Editor's Choice]

    Oct 1, 2024, 00:00

  • Author Reply

    Oct 1, 2024, 00:00

  • Mapping the Lequesne Functional Index Into the EQ-5D-5L Utility Index in Patients With Knee Osteoarthritis

    Oct 1, 2024, 00:00

  • Traditional Methods Hold Their Ground Against Machine Learning in Predicting Potentially Inappropriate Medication Use in Older Adults [Editor's Choice]

    Oct 1, 2024, 00:00

  • Generating Utilities for the Château-Santé Base: A Novel, Generic, and Patient-Centered Health-Outcome Measure

    Oct 1, 2024, 00:00

  • Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Li ...

    Oct 1, 2024, 00:00

  • Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program [Editor's Choice]

    Oct 1, 2024, 00:00

  • Cost-of/Burden-of-Illness Studies: Steps Backward?

    Oct 1, 2024, 00:00

  • Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge

    Oct 1, 2024, 00:00

  • Author Reply

    Oct 1, 2024, 00:00

  • A Tutorial on Value-Based Adaptive Designs: Could a Value-Based Sequential 2-Arm Design Have Created More Health Economic Value for the Big CACTUS Trial? [Editor's Choice]

    Oct 1, 2024, 00:00

  • Does Willingness to Pay Differ for Mental and Physical Health?

    Oct 1, 2024, 00:00

  • Sales Revenues for New Therapeutic Agents Approved by the United States Food and Drug Administration From 1995 to 2014

    Oct 1, 2024, 00:00

  • Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union’s Regulation on Health Technology Assessment for Vaccines

    Oct 1, 2024, 00:00

  • Editorial Board

    Sep 27, 2024, 09:02

  • Further Evidence of Feasibility, Validity, and Reliability of Quality of Life-Aged Care Consumers: Evidence From Home-Based Care Settings

    Sep 1, 2024, 00:00

  • Facilitators and Barriers in the Implementation and Adoption of Patient-Reported Outcomes Measurements in Daily Practice

    Sep 1, 2024, 00:00

  • A Feasible Estimation of a “Corrected” EQ-5D Social Tariff

    Sep 1, 2024, 00:00

  • Experience Counts: Unveiling Patients’ Willingness to Pay for Remote Monitoring and Patient Self-Measurement

    Sep 1, 2024, 00:00

  • A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development [Editor's Choice]

    Sep 1, 2024, 00:00

  • Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks [Editor's Choice]

    Sep 1, 2024, 00:00

  • Psychometric Performance of the EQ Health and Wellbeing Short in a United Kingdom Population Sample [Editor's Choice]

    Sep 1, 2024, 00:00

  • A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results?

    Sep 1, 2024, 00:00

  • Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease

    Sep 1, 2024, 00:00

  • Table of Contents

    Sep 1, 2024, 00:00

  • Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review

    Sep 1, 2024, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI) [Editor's Choice]

    Sep 1, 2024, 00:00

  • A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices

    Sep 1, 2024, 00:00

  • Putting a Dollar Value on Informal Care Time Provided to People Living With Dementia: A Discrete Choice Experiment

    Sep 1, 2024, 00:00

  • Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian Cancer

    Sep 1, 2024, 00:00

  • Testing “Pits” Time Trade-Off: Can Data Quality be Improved by Removing Death From Valuation of Health States? [Editor's Choice]

    Sep 1, 2024, 00:00

  • Editorial Board

    Aug 27, 2024, 14:04

  • Editorial Board

    Aug 7, 2024, 11:53

  • Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®)

    Aug 1, 2024, 00:00

  • It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties [Editor's Choice]

    Aug 1, 2024, 00:00

  • Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review [Editor's Choice]

    Aug 1, 2024, 00:00

  • Table of Contents

    Aug 1, 2024, 00:00

  • The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States [Editor's Choice]

    Aug 1, 2024, 00:00

  • Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation?

    Aug 1, 2024, 00:00

  • Utilization, Expenditure, and Treatment Patterns Associated With Calcitonin Gene-Related Peptide Monoclonal Antibodies Reimbursed Subject to a Managed Access Protocol in Ireland

    Aug 1, 2024, 00:00

  • Navigating Public Policy Responses to a Pandemic: The Balancing Act Between Physical Health, Mental Health, and Household Income

    Aug 1, 2024, 00:00

  • Treatment Effect Waning Assumptions: A Review of National Institute of Health and Care Excellence Technology Appraisals [Editor's Choice]

    Aug 1, 2024, 00:00

  • The Long COVID Symptoms and Severity Score: Development, Validation, and Application

    Aug 1, 2024, 00:00

  • EQ-5D-5L Population Norms for China Derived From a National Health Survey

    Aug 1, 2024, 00:00

  • Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United States

    Aug 1, 2024, 00:00

  • Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma

    Aug 1, 2024, 00:00

  • Validating Health Economic Models With the Probabilistic Analysis Check dashBOARD

    Aug 1, 2024, 00:00

  • Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019

    Aug 1, 2024, 00:00

  • A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity

    Aug 1, 2024, 00:00

  • Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L [Editor's Choice]

    Aug 1, 2024, 00:00

  • How Do the Institute for Clinical and Economic Review’s Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee’s Assessments of Added Benefit? A Qualitative Study

    Aug 1, 2024, 00:00

  • Social Decision-Making Analysis: A General Approach to Inform Decisions on Resources in the Public Sector [Editor's Choice]

    Jul 1, 2024, 00:00

  • Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample [Editor's Choice]

    Jul 1, 2024, 00:00

  • Understanding the Complex Interactions Between Interventions, Well-Being, and Resource Allocation

    Jul 1, 2024, 00:00

  • Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions

    Jul 1, 2024, 00:00

  • Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A Cost-Effectiveness Analysis

    Jul 1, 2024, 00:00

  • Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation

    Jul 1, 2024, 00:00

  • Values Beyond “Health” in Budget-Constrained Healthcare Systems [Editor's Choice]

    Jul 1, 2024, 00:00

  • The Ceiling Effects of EQ-5D-3L and 5L in General Population Health Surveys: A Systematic Review and Meta-Analysis

    Jul 1, 2024, 00:00

  • From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year [Editor's Choice]

    Jul 1, 2024, 00:00

  • A Head-to-Head Comparison of EQ-HWB and EQ-5D-5L in Patients, Carers, and General Public in China

    Jul 1, 2024, 00:00

  • Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors

    Jul 1, 2024, 00:00

  • Construct Validity, Reliability, and Responsiveness of the 10-Item Well-Being Instrument for Use in Economic Evaluation Studies [Editor's Choice]

    Jul 1, 2024, 00:00

  • Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial

    Jul 1, 2024, 00:00

  • Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making

    Jul 1, 2024, 00:00

  • Editorial Board

    Jul 1, 2024, 00:00

  • Comparison of the EQ-HWB and EQ-HWB-S With Other Preference-Based Measures Among United States Informal Caregivers [Editor's Choice]

    Jul 1, 2024, 00:00

  • Table of Contents

    Jul 1, 2024, 00:00

  • Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study

    Jul 1, 2024, 00:00

  • The Measurement Properties of the EQ-HWB and the EQ-HWB-S in Italian Population: A Comparative Study With EQ-5D-5L

    Jul 1, 2024, 00:00

  • Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement

    Jul 1, 2024, 00:00

  • Subjective Well-Being Population Norms and Inequalities in Hungary: A Large Cross-Sectional, Internet-Based Survey

    Jul 1, 2024, 00:00

  • Editorial Board

    Jun 12, 2024, 08:53

  • HTA6 Use of Medical Device Assessment Criteria in CONITEC Evaluations

    Jun 1, 2024, 00:00

  • HSD121 Real-World Prescribing of Tirzepatide Labeled for Obesity in the United States

    Jun 1, 2024, 00:00

  • EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction

    Jun 1, 2024, 00:00

  • EE19 Cost-Effectiveness Analysis of Infliximab, Adalimumab, and Certolizumab for Crohn's Disease: A Markov Model Study

    Jun 1, 2024, 00:00

  • EE293 A Framework to Assess Uncertainties of Polygenic Risk Scores in Disease Screening and Prevention in Cost-Effectiveness Analyses

    Jun 1, 2024, 00:00

  • PCR188 Compliance and Design Features of Electronic Participant-Reported Dosing Diaries

    Jun 1, 2024, 00:00

  • MSR69 Systematic Review and Meta-Analysis of Fecal Incontinence Prevalence and Population Estimates

    Jun 1, 2024, 00:00

  • SA28 Using Linked Claims-EHR Data: The Added Value When Assessing Comorbidity Burden Among Patients With Asthma

    Jun 1, 2024, 00:00

  • EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective

    Jun 1, 2024, 00:00

  • SA24 CHIME2 (Chinese Hong Kong Integrated Modeling and Evaluation): An Updated Model to Simulate Lifetime Health Outcomes of Patients with Type 2 Diabetes

    Jun 1, 2024, 00:00

  • CO127 Newer Glucose-Lowering Drugs and Risk of Suicide: A Network Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • MSR9 Can Artificial Intelligence Tools Enhance Data Abstraction During Systematic Literature Reviews?

    Jun 1, 2024, 00:00

  • HSD1 Assessing Community Pharmacist Expectation, Satisfaction, and Intentions in the Wasfaty E-Servi Using the Expectation Conformation Theory

    Jun 1, 2024, 00:00

  • CO206 The Clinical and Financial Impact of Sustained Annual Wellness Visit Engagement in the Blue Cross and Blue Shield of Louisiana Medicare Advantage Population

    Jun 1, 2024, 00:00

  • HPR4 What Makes an Orphan Medicine? Determining Characteristics of Non-Oncology Orphan Approvals from 2015-2022

    Jun 1, 2024, 00:00

  • PCR196 Psychometric Validation of the PROMIS Fatigue-Short Form 7A in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

    Jun 1, 2024, 00:00

  • MT15 Postoperative Clinical and Economic Outcomes of Patients With Reverse or Anatomic Total Shoulder Arthroplasty at One Year: A Retrospective, United States Hospital Billing Database Analysis

    Jun 1, 2024, 00:00

  • EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients

    Jun 1, 2024, 00:00

  • HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey

    Jun 1, 2024, 00:00

  • HTA18 Heading into the Unknown: How Will JCA Implementation Affect Global Launch Strategies?

    Jun 1, 2024, 00:00

  • CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Specific Adverse Events in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • EPH119 Public Health Results in the Department of Bolívar, Colombia: An Analysis of Indicators in 2023

    Jun 1, 2024, 00:00

  • CO39 Influence of Socioeconomic Status on Breast Cancer Treatment in the US: Preliminary Results from a Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR66 Improving Quality of Life in Endometriosis Patients: A Study on Lifestyle and Pain Scores

    Jun 1, 2024, 00:00

  • EE485 Cost-Effectiveness of Active Surveillance for Incidentally Detected Early-Staged Papillary Thyroid Cancer: A Microsimulation Study

    Jun 1, 2024, 00:00

  • MSR61 Perceptions of the Feasibility of AI-Based Machine Translation for Linguistic Validation

    Jun 1, 2024, 00:00

  • P12 Racial and Ethnic Fairness in Risk Prediction Models for Cardiovascular Diseases Among U.S. Adults

    Jun 1, 2024, 00:00

  • EE8 Targeted Literature Review for Estimating Median Age of Causal Human Papilloma Virus Infection to Oropharyngeal Cancer

    Jun 1, 2024, 00:00

  • EPH108 Clopidogrel Resistance in Patients With Recurrent Ischaemic Stroke on Dual Antiplatelet Therapy and Its Economic Impact in a Lower-Middle Income Country: A Single Centered Study in Southern India

    Jun 1, 2024, 00:00

  • EPH213 Burden of Heart Failure After Hospitalization for Myocardial Infarction in the United States: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • PCR209 Joint Modeling of Progression-Free Survival (PFS) and Patient-Reported Symptoms Among Relapsed/Refractory Multiple Myeloma (RRMM) Patients

    Jun 1, 2024, 00:00

  • EE164 A Systematic Review and Meta-Analysis of Economic Burden of Breast Cancer Among Adult Females: Based on the Perspective of Social Development Level and Progression of Disease

    Jun 1, 2024, 00:00

  • EE328 Direct Medical Costs in Patients with Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC) in Colombia

    Jun 1, 2024, 00:00

  • EPH211 Treatment Patterns and Clinical Characteristics of Patients Diagnosed with Metastatic NSCLC in Hmo from Colombia: A Real Word Evidence Study

    Jun 1, 2024, 00:00

  • RWD166 Evaluation of the One-Day Surgical Performance of the Hungarian Universities in the Obstetrics and Gynecology Medical Field

    Jun 1, 2024, 00:00

  • MSR58 Comparing Predictive Models: Traditional Versus Modern Statistical Approaches for Economic Outcomes in Major Depressive Disorder

    Jun 1, 2024, 00:00

  • HPR38 Estimating the Outcome Disparities in BIPOC and Economically-Disadvantages Patients With Systemic Lupus Erythematosus (SLE)

    Jun 1, 2024, 00:00

  • MSR5 Leveraging Machine Learning To Understand Pet Owner Experiences of Feline Pruritus Through Social Media Listening

    Jun 1, 2024, 00:00

  • HPR100 Health Technologies Value Assessment Through the Lens of Health Equity; How Far From Being Incorporated Routinely? An Environmental Scan of Health Equity Frameworks and Policy Gaps

    Jun 1, 2024, 00:00

  • MT36 Assessment and Comparison of the Manual Steps Required to Perform Whole Blood Processing Using a Semi-Automated Method Versus a Fully Automated Method

    Jun 1, 2024, 00:00

  • EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review

    Jun 1, 2024, 00:00

  • OP2 Health Insurance Cost Management: Perspective from the Caribbean Region, Colombia

    Jun 1, 2024, 00:00

  • RWD158 Assessing RSV Vaccination Trends in the Context of Seasonal RSV Diagnoses Using Near Real-Time Administrative Claims

    Jun 1, 2024, 00:00

  • RWD183 Experience in Implementing Clinical Trial to Real-World Data (RWD) Linkage

    Jun 1, 2024, 00:00

  • EE14 Cost of Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

    Jun 1, 2024, 00:00

  • EE156 Temporal Excess Hospital Costs of Complications in Chinese Patients With Type 2 Diabetes: Results from the Joint Asia Diabetes Evaluation (JADE) Register (2007-2018)

    Jun 1, 2024, 00:00

  • EPH226 Associations between Antimicrobial Susceptibility of Streptococcus Pneumoniae and Disease Severity Outcomes in Older Adults with Invasive Pneumococcal Disease in Sao Paulo, Brazil

    Jun 1, 2024, 00:00

  • RWD3 Review of the Use of Electronic Health Records for Advancing Schizophrenia Research in the UK

    Jun 1, 2024, 00:00

  • EPH42 Evaluating the Public Health Impact of Dengue Vaccination in Indonesia: A Dynamic Transmission Modeling Assessment amidst Uncertainties in the Implementation Strategies

    Jun 1, 2024, 00:00

  • RWD28 Adherence to Janus Kinase Inhibitors Among Older Adults with Rheumatoid Arthritis Initiating New Treatment

    Jun 1, 2024, 00:00

  • HSD51 Evaluation of the Healthcare System Burden Associated With Intravenous Treatment for Paroxysmal Nocturnal Hemoglobinuria

    Jun 1, 2024, 00:00

  • EE307 Economic Evaluation of a Screening Programme for Diabetes, Hypertension and Hyperlipidaemia in Middle-Aged Adults in Hong Kong: A Simulation Analysis

    Jun 1, 2024, 00:00

  • MSR64 Using Large Language Models To Extract PD-L1 Testing Details From Electronic Health Records

    Jun 1, 2024, 00:00

  • HPR149 Americans' Views on Health Inequality in the United States: Results from a General Population Survey

    Jun 1, 2024, 00:00

  • RWD146 Characterization of Chronic Kidney Disease Patients By eGFR Status Using Health Insurance Claims Linked to Lab Testing Data

    Jun 1, 2024, 00:00

  • PCR103 Young People’s Preferences Towards Web-Based Mental Health Interventions for Anxiety and Depression: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • CO144 Association of All-Cause and Cause-Specific Mortality with High-Risk NAFLD/NASH in US Adults, NHANES III (1988-1994) Linked to Mortality Data through 2019

    Jun 1, 2024, 00:00

  • MSR17 Leveraging Large Language Models (LLMs) for Classifying Peer Reviewed Publications for Literature Review

    Jun 1, 2024, 00:00

  • MT23 The Changing Healthcare Landscape of Lumbar Spinal Fusion: Two-Year Claims Database Analysis

    Jun 1, 2024, 00:00

  • EPH19 Opioid-Related Overdose Death Rates in the US From 2005 to 2021

    Jun 1, 2024, 00:00

  • EE18 Burden of Illness for Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States

    Jun 1, 2024, 00:00

  • CO118 Sickle Cell Disease Outcomes in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EPH107 Characteristics of the COVID-19 Epidemic in Three Hungarian Disctricts

    Jun 1, 2024, 00:00

  • PCR199 Advancing Patient-Centered Outcomes Research for Rare Diseases: A Mixed-Methods Approach

    Jun 1, 2024, 00:00

  • RWD164 Evidence Gap Analysis of the Burden of Disease in Thyroid Eye Disease

    Jun 1, 2024, 00:00

  • Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire

    Jun 1, 2024, 00:00

  • HSD45 Effectiveness of Aseptic and Disinfection Measures in Dental Offices in Barranquilla, Colombia

    Jun 1, 2024, 00:00

  • CO180 Newer Glucose-Lowering Drugs and Risk of Depression: A Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • HSD112 Product Entry Sequence and Priority of Follow-on Drug Use: A Case Study of Second-Generation Antipsychotics with Long-Acting Injections

    Jun 1, 2024, 00:00

  • CO55 Incidence of Adverse Events with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review of Literature

    Jun 1, 2024, 00:00

  • EE501 Estimating the Impact of Delayed Treatment for Major Depressive Disorder Using a Continuous-Time Patient-Level Simulation Model

    Jun 1, 2024, 00:00

  • HTA27 An Analysis of Manufacturer and Patient Engagement with Institute for Clinical and Economic Review Assessments

    Jun 1, 2024, 00:00

  • EE168 Avoidable Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated with Darolutamide

    Jun 1, 2024, 00:00

  • The Patient and Caregiver Perspective for Healthcare Decision-Making

    Jun 1, 2024, 00:00

  • EPH120 Incidence, Prevalence and Clinical Characteristic of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • HPR141 Model Analysis on Budget Impact and Patients’ Burden of National Price-Negotiated Drugs and Different Reimbursement Payment Modes in China: Hyperkalemia As an Example

    Jun 1, 2024, 00:00

  • EE61 Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Mexican Adults Population

    Jun 1, 2024, 00:00

  • RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan

    Jun 1, 2024, 00:00

  • EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis

    Jun 1, 2024, 00:00

  • CO41 Comparative Effectiveness of Glucagon-like Peptide 1 Agonists Vs Dipeptidyl Peptidase 4 Inhibitors on Liver Outcomes in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Fatty Liver Disease

    Jun 1, 2024, 00:00

  • EPH8 Comparison of Patient Identification Methodologies in Chronic Inflammatory Demyelinating Polyneuropathy Using United States Administrative Claims Data

    Jun 1, 2024, 00:00

  • EE417 Healthcare Resource Use and Costs of Care in HR+/HER2- Metastatic Breast Cancer: A Retrospective US Claims Data Study

    Jun 1, 2024, 00:00

  • PCR225 The Caregiver Perspective on Dry Age-Related Macular Degeneration: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • HPR77 CMS Coverage Lift on PET Beta Amyloid Imaging Impact on mAb Treatment and Beneficiary Out-Of-Pocket Spending

    Jun 1, 2024, 00:00

  • SA39 Exploring the Landscape of Genetically Modified Natural Killer Cell (GMNKC) Therapies: A Review of Clinical Trials Indexed on ClinicalTrials.gov

    Jun 1, 2024, 00:00

  • RWD129 Trends in GLP-1 Receptor Agonist Dispensing Among US Patients Without Type 2 Diabetes Using Real World Data

    Jun 1, 2024, 00:00

  • RWD154 Evaluation of Mortality Data Sources for Use in Real-Word Data Analyses

    Jun 1, 2024, 00:00

  • PT20 Gleaning Novel Insights from Real World Data: A Machine-Learning Guided Analytical Framework

    Jun 1, 2024, 00:00

  • EPH176 Comparison of Superoxide Dismutase Activities (Mn-SOD AND Cu/Zn-SOD) in Patients Infected with Dengue Virus or Zika Virus

    Jun 1, 2024, 00:00

  • RWD144 Predictive Risk Score for Nonalcoholic Steatohepatitis (NASH) Among Patients in the Department of Defense Population

    Jun 1, 2024, 00:00

  • Modeling for HTA

    Jun 1, 2024, 00:00

  • HTA76 Insights into Health Technology Reassessment in Fran A Comprehensive Analysis of Key Outcomes and Manufacturers Engagement (2022-2023)

    Jun 1, 2024, 00:00

  • HPR91 Public Sector Replacement of Privately Funded Pharmaceutical RD: Cost and Efficiency Considerations

    Jun 1, 2024, 00:00

  • EE340 Real-World Healthcare Resource Utilization and Costs of Patients with Alzheimer’s Disease By Stage: A Retrospective Observational Study

    Jun 1, 2024, 00:00

  • EPH63 Epidemiological Disease Burden of Female Infertility of Other Origin Based on Routinely Collected Health Insurance Claims Data between 2010-2019

    Jun 1, 2024, 00:00

  • MSR52 Assessing the Representativeness of Provider Encounter Data From a Large Claims Database on Adults With Major Depression

    Jun 1, 2024, 00:00

  • P60 Evaluating Dynamic Treatment Using a Target Trial: The Real-World Effectiveness of Adding Oral Selexipag to a Double Oral Therapy for the Treatment of Patients With Pulmonary Arterial Hypertension

    Jun 1, 2024, 00:00

  • CO84 Racial/Ethnic Differences in Healthcare Resource Utilization Among Patients With Amyotrophic Lateral Sclerosis in Texas

    Jun 1, 2024, 00:00

  • EE3 Cost Effectiveness Model on Four Preventive Treatment for Clostridioides Difficile Infection Recurrence From a US Payer Perspective

    Jun 1, 2024, 00:00

  • HSD31 Analyzing Factors Affecting Length of Emergency Department Stay in Patients With Hemophilia

    Jun 1, 2024, 00:00

  • CO146 Treatment Use and Overall Survival of Patients with Unresectable/Metastatic Melanoma in Colombia: A Real World Study

    Jun 1, 2024, 00:00

  • PCR151 Understanding the Patient Perspectives of Post-Discharge Care and Impact of Treatment in the First Year Post-Acute Myocardial Infarction

    Jun 1, 2024, 00:00

  • HSD57 Current Status of Off-Label IV Ketamine Utilization for Mood Disorders: A Nationwide Survey of Ketamine Clinics, Treatment Processes, and Provider Perceptions of Outcomes

    Jun 1, 2024, 00:00

  • MSR18 Improving the Performance of Generative AI to Achieve 100% Accuracy in Data Extraction

    Jun 1, 2024, 00:00

  • EPH149 Regional Dynamics and Prevalence of COVID-19 Variants in US Health and Human Services Regions

    Jun 1, 2024, 00:00

  • HSD48 US Infusion Center Capacity to Accommodate Anti-Amyloid Treatments for Alzheimer’s Disease: A Quantitative Survey

    Jun 1, 2024, 00:00

  • EE510 Navigating Economics of Telehealth in Oncology

    Jun 1, 2024, 00:00

  • CO115 Long-Term Post-Recurrence Survival (PRS) Outcomes for Stage IIB/C Melanoma Patients in Real-World (RW) Settings: Analyses from a Longitudinal Electronic Health Record Database in the United States

    Jun 1, 2024, 00:00

  • EE514 Private Hospital Acute Stroke Care Costs: Patient's Viewpoint

    Jun 1, 2024, 00:00

  • CO124 Association Between Quality of Life and Viral Load Among People With HIV in the Current Antiretroviral Era

    Jun 1, 2024, 00:00

  • PT44 Prevalence of Comorbidities and Hospitalization in the 65 and over SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) Patient Population: A Comparative Analysis of the FORWARD Lupus Registry and Medicare Data in the US (2017-2021)

    Jun 1, 2024, 00:00

  • EE333 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the U.S.: An Updated Analysis

    Jun 1, 2024, 00:00

  • RWD137 Automated Non-Interventional Research Protocol Generation: A Case Study in Melanoma

    Jun 1, 2024, 00:00

  • MSR30 Use of Natural Language Processing to Augment Real-World Data (RWD) and Identify Eligible Patients at Scale for Oncology Studies

    Jun 1, 2024, 00:00

  • EPH183 The Association Between the Minority Health Social Vulnerability Index and Pneumococcal Disease Incidence Among Medicare Beneficiaries (2016-2019)

    Jun 1, 2024, 00:00

  • EE87 Time-Driven Activity Based Costing of Advanced Ovarian Cancer From the Perspective of a Brazilian Public Hospital

    Jun 1, 2024, 00:00

  • EE22 COPD-Related Healthcare Resource Utilization Before and After Initiating Inhaled Corticosteroid-Containing Maintenance Regimens: Real World Claims Data

    Jun 1, 2024, 00:00

  • Study Approaches

    Jun 1, 2024, 00:00

  • CO104 Clinical Outcomes of Second-Line and Beyond (2L+) Treatments (TXS) in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE528 Comparative Effectiveness Modeling of an Anti-Pd-1 Antibody Drug Intervention for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the U.S.

    Jun 1, 2024, 00:00

  • EPH134 Difference in E-Cigarette Use Prevalence in Adolescents between 2019 and 2021 in Georgia, United States

    Jun 1, 2024, 00:00

  • PCR30 An Investigation of Patient Journey Assessment in Rare Disease

    Jun 1, 2024, 00:00

  • EE33 Cost-Effectiveness of Aducanumab, Lecanemab, and Donanemab for Early Alzheimer Disease in the US

    Jun 1, 2024, 00:00

  • CO13 A Claims Analysis To Characterize All-Cause Mortality in Patients With Generalized Pustular Psoriasis in the United States

    Jun 1, 2024, 00:00

  • EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • PCR229 Development of the ADHD Treatment Satisfaction Questionnaire (ATSQ) for Use with Children, Adolescents, and Their Caregivers

    Jun 1, 2024, 00:00

  • RWD54 Comparative Analysis of Different Methods of Disease Progression Data Capture in Patients With Metastatic Castration-Resistant Prostate Cancer

    Jun 1, 2024, 00:00

  • PCR49 Mapping and Linking between the EQ-5D-5L and the PROPr in the United States

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • EE355 Can Large Language Models Generate Conceptual Health Economic Models?

    Jun 1, 2024, 00:00

  • PCR62 Household Costs for Home, Vehicle, and Medical Equipment Expenditures to Accommodate Functional Impairments for Individuals with Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • MSR45 Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients With Atrial Fibrillation and Cancer

    Jun 1, 2024, 00:00

  • SA72 Health System As an Adaptative Complex System for Open Innovation

    Jun 1, 2024, 00:00

  • PT7 Engaging Patients With Rare Disease in Identifying Meaningful Approaches to Integrate Patient-Centered Outcomes in Comparative Effectiveness Research and Value Assessment

    Jun 1, 2024, 00:00

  • SA37 Costs and Quality of Life in Clinical Trials of Heart Failure in the US

    Jun 1, 2024, 00:00

  • MSR105 Proportional Randomization Method to Identify Index Line of Therapy in Externally Controlled Trials

    Jun 1, 2024, 00:00

  • CO8 Leading Predictors of Incident Hypertension Among Patients with Cancer in Community Health Centers: A Machine Learning Approach with Shapley Additive Explanations Using Electronic Health Records

    Jun 1, 2024, 00:00

  • RWD26 Tokenization-Linked Social Determinants of Health (SDoH) Data: A Gateway to Enhanced Understanding of Rare Disease Clinical Trial Populations

    Jun 1, 2024, 00:00

  • EE115 Clinical and Economic Impact of Glucagon-like Peptide-1 Agonists in Patients with Obstructive Sleep Apnea: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • EE79 Real-World Clinical and Economic Burden of Primary Biliary Cholangitis in the United States

    Jun 1, 2024, 00:00

  • MSR83 Predicting Optimal Treatment Regimen to Improve Outcomes of Patients With CLL/SLL Using Random Survival Forest

    Jun 1, 2024, 00:00

  • PCR245 Patient Characteristics and Improved Outcomes With Greater Adherence to Acthar® Gel in Nephrotic Syndrome

    Jun 1, 2024, 00:00

  • SA62 Treatment Patterns Following First Line CDK4/6 Inhibitor Progression in HR+, HER2- Metastatic Breast Cancer

    Jun 1, 2024, 00:00

  • EE258 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for High-Risk Patients in Chile

    Jun 1, 2024, 00:00

  • HSD99 Impact of Pink October in Mammographic Screening in a Health Care Plan in Brazil

    Jun 1, 2024, 00:00

  • EPH21 Burden of Unresectable/Metastatic Melanoma(u-mMel) and Advanced/Metastatic Colorectal Cancer(mCRC), and Their Associated BRAF-mutations in Four LATAM Countries: A Targeted Literature Review of Epidemiological and Economic Evidence

    Jun 1, 2024, 00:00

  • RWD63 Utilizing AI/ML for Insight Into the Transition Factors From Traditional (Non-Nano Delivery) to Nano Drug Delivery of Paclitaxel in Breast Cancer Patients

    Jun 1, 2024, 00:00

  • RWD69 Utilization of Current Procedural Terminology Codes in Pharmacists' Services Using Medicare Data Claims

    Jun 1, 2024, 00:00

  • SA7 Outcomes With Novel Therapies for Relapsed or Refractory Follicular Lymphoma: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer

    Jun 1, 2024, 00:00

  • PCR171 Measuring Disease and Treatment-Related Symptoms and HRQoL Impacts in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) Using the EORTC Qlq-C30 and NMIBC-24: Qualitative Literature Review and Gap Analysis

    Jun 1, 2024, 00:00

  • HPR21 Healthcare Expenditure and Its Association with Under Five Mortality: A Cross-Country Analysis in the Eastern Mediterranean Region

    Jun 1, 2024, 00:00

  • PCR31 Crosscultural Adaptation of the Hungarian Version of Stroke Impact (SIS)

    Jun 1, 2024, 00:00

  • HSD35 Real-World Treatment Patterns and Treatment Sequences in the Metastatic Castration-Resistant Prostate Cancer Settings across Europe

    Jun 1, 2024, 00:00

  • EE70 The Cost of Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant (LTx) Recipients By Stage 0-4: A Claims Database Analysis

    Jun 1, 2024, 00:00

  • HSD120 Effectiveness of Pharmacist-Led Interventions on Medication Use and Related Health Outcomes in Patients With Alzheimer's Disease and Related Dementias: A Systematic Review

    Jun 1, 2024, 00:00

  • EPH224 Effectiveness of COVID-19 Vaccines in Colombia: Findings from Two Highly Specialized Healthcare Centers

    Jun 1, 2024, 00:00

  • EE172 Quantifying the Relationship between Time to Diagnosis and Potential System Level Burden in Obstructive Hypertrophic Cardiomyopathy (HCM)

    Jun 1, 2024, 00:00

  • EPH38 Antimicrobial Susceptibility of Klebsiella Pneumoniae Clinical Isolates From the Lower Respiratory Tract Infection During the COVID-19 Pandemic in Brazil (SMART 2020-2021)

    Jun 1, 2024, 00:00

  • EE160 Evidence to Inform Forecasts of Biopharmaceutical Policy Impact

    Jun 1, 2024, 00:00

  • HPR86 The Impact of Mandated Prescription Drug Monitoring Program Registration on Prescription Opioid-Related Mortality in California

    Jun 1, 2024, 00:00

  • RWD77 Time to Reimbursement in Kazakhstan for Novel Biologic Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • EE113 Impact of Type 1 Diabetes and Severe Hypoglycemia on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • RWD160 An Episode-Based Analysis in a Medicare Advantage Population to Identify the Cost Impact of Virtual-First Care for Common Acute Conditions

    Jun 1, 2024, 00:00

  • SA10 The Safety and Effectiveness of Intraoperative Radiotherapy With Low-Energy X-Ray for Breast Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • EPH202 Assessing Trends in Utilization and Off-Label Prescribing for Ozempic, a Glucagon-like Peptide Receptor Agonist

    Jun 1, 2024, 00:00

  • EE479 Adverse Event Costs Associated With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States, Italy, Portugal, and Spain

    Jun 1, 2024, 00:00

  • P56 Extraction of Inflammatory Bowel Disease Severity Scores from Unstructured Clinical Notes Using a Retriever-Reader Architecture

    Jun 1, 2024, 00:00

  • HPR44 Implications of Regulatory Telemedicine Prescribing Flexibilities on Patients With Opioid Use Disorder

    Jun 1, 2024, 00:00

  • EPH184 Patient Journey of Head Neck Squamous Cell Cancer in Oncology Centers in Colombia

    Jun 1, 2024, 00:00

  • PCR89 Impact of Dosing and Administration on HRQoL Among People With Hemophilia: A Time Trade-Off Study Including 2.250 Respondents in the UK, Canada and the US

    Jun 1, 2024, 00:00

  • RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data

    Jun 1, 2024, 00:00

  • CO106 Clinical Outcomes of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria in Colombian Patients

    Jun 1, 2024, 00:00

  • HTA57 Uptake of Early Health Technology Assessment in the United States (US): A Literature Review of Empirical Studies

    Jun 1, 2024, 00:00

  • MSR47 Assessing the Impact of the Prior Distribution for the Within-Study Correlation in Bivariate Network Meta-Analysis: A Case Study in Relapsed/Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • CO99 Validation of Overall Survival (OS) Extrapolations Using 5-Year Follow-up Data From the Keynote-177 MSI-H/dMMR Metastatic Colorectal Cancer (mCRC) Study

    Jun 1, 2024, 00:00

  • EE133 Burden of Illness for Adults Living With Primary Chronic Immune Thrombocytopenia in the United States

    Jun 1, 2024, 00:00

  • CO53 Real-World Evidence of the Effectiveness of Inhaled Corticosteroid-Containing Therapies in Reducing Exacerbations and Medical Costs in COPD

    Jun 1, 2024, 00:00

  • EPH165 The Fiscal Costs of a Public Health Crisis: Lessons From Zika in the United States

    Jun 1, 2024, 00:00

  • SA22 Does the Use of Investigator-Choice Comparator Arms in Oncology Clinical Trials Influence Payer Assessments Outcomes?

    Jun 1, 2024, 00:00

  • EPH241 Benzodiazepines and Adrenergic beta2-Agonists: A Synergistic Impact on Health-Related Quality of Life Among Older Adults with Prostate Cancer

    Jun 1, 2024, 00:00

  • HSD29 Predicting Psoriasis Area and Severity Index From Physician Global Assessment and Body Surface Area in the Real-World Dermatology Setting

    Jun 1, 2024, 00:00

  • EE324 Describing the Clinical and Economic Burden of Women Diagnosed With Uterine Fibroid (UF) and Heavy Menstrual Bleeding (HMB) in a United States (US) Commercial Database 2015-2022

    Jun 1, 2024, 00:00

  • MSR34 Diversity in Clinical Trials: Life Science Initiatives and Challenges in Light of the FDA’s Latest Guidance

    Jun 1, 2024, 00:00

  • MSR100 Prediction Models for Cardiotoxicity Induced By Anticancer Drug in Women with Breast Cancer

    Jun 1, 2024, 00:00

  • P6 The Effect of Formulary Restrictions on the Disease Outcomes Among Medicare Beneficiaries With Multiple Sclerosis in the United States

    Jun 1, 2024, 00:00

  • CO105 Disease Burden and Treatment in Patients with Essential Tremor in the United States: Real-World Evidence from a Cross-Sectional Survey of Physicians and Patients

    Jun 1, 2024, 00:00

  • EPH163 Off-Label Use of Semaglutide in the United States: Increasing Prevalence, Variability in Prescribing Provider Specialty, and Patient Characteristics

    Jun 1, 2024, 00:00

  • EE448 A Recent Adoption of Cost-Effectiveness Thresholds in Brazil and Its Repercussions

    Jun 1, 2024, 00:00

  • HSD107 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries by Sex, Age, and Race/Ethnicity

    Jun 1, 2024, 00:00

  • CO156 Indirect Treatment Comparison (ITC) of Cabotegravir Long Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Versus No Prep for HIV Prevention

    Jun 1, 2024, 00:00

  • HTA23 Caregiver Health-Related Quality of Life in National Institute for Health and Care (NICE) Appraisals: From Inception to 2023

    Jun 1, 2024, 00:00

  • EE85 Sources of Increased Expenditures for Young Children with Autism Spectrum Disorder Diagnoses in Employer-Sponsored Plans, 2016–2021

    Jun 1, 2024, 00:00

  • EE357 Using a Computer Vision-Based System for Reading Skin Prick Test Results: A Cost-Minimisation Analysis

    Jun 1, 2024, 00:00

  • SA68 Assessment of Real-World Data Sources and a Hybrid Approach in Real-World Evidence Generation Using Unharmonized Data Sources

    Jun 1, 2024, 00:00

  • PCR238 Estimating Health State Utilities (HSUS) for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in the United States

    Jun 1, 2024, 00:00

  • PCR92 Association of Rheumatoid Arthritis (RA) Patient Characteristics and Perceived Treatment Satisfaction, RA Impact on Life, and Task Difficulty with Promis Measures’ Physical Functioning and Upper Extremity Scores

    Jun 1, 2024, 00:00

  • EE64 Treatment-Related Costs of Ponatinib and Asciminib in Adults Patients with T315I-Positive Chronic Phase Chronic Myeloid Leukemia with Resistance or Intolerance to at Least Two Prior Kinase Inhibitors in the United States

    Jun 1, 2024, 00:00

  • EE274 Cost-Effectiveness Analysis of Large-Scale Screening for Celiac Disease in the Pediatric Population

    Jun 1, 2024, 00:00

  • HPR113 Equity in Antenatal Care Quality: An Analysis of 11.382 Cases from 23 Municipalities in Colombia

    Jun 1, 2024, 00:00

  • CO2 Association Between Classes of Antidiabetic Medications and Their Potential Risk or Protective Effects on Cancer: A Systematic Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE359 Economic Burden of Managing Acute and Chronic Pain in the United States: National Estimates from 2022 Data

    Jun 1, 2024, 00:00

  • MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare

    Jun 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16 (current)
  • 17
  • 18
  • 19
  • 20
  • »